MONTREAL, Aug. 27, 2012 /PRNewswire/ -- Tomas Puusepp, President and CEO of Elekta, a global leader in developing innovative solutions for treating cancer, will be participating in the 2012 World Cancer Leaders' Summit today in Montreal. Elekta also is a sponsor and exhibitor for the biennial UICC World Cancer Congress, Aug. 27-30 at the Palais des congres de Montreal.
"We are dedicated to contributing our time, talents and resources to advancements in cancer care," says Puusepp. "I'm honored to join international cancer leaders in Montreal where Elekta is engaged and committed to bringing hope to patients with cancer."
The World Cancer Congress gives participants the opportunity to exchange ideas and learn about solutions for reducing the impact of cancer on communities around the world. It will highlight how knowledge gained through research and practice can benefit people living with and affected by cancer.
Puusepp notes that Elekta is committed to supporting local cancer communities in Montreal and throughout Canada. Montreal is home to one of Elekta's key research and development centers, and some of the company's Canadian customers include McGill University Hospital Centre and Cancer Care Ontario, one of North America's largest cancer centers.
"We are privileged to have played a part in the establishment of this important research and development facility in Canada," he says. "Our Montreal team has been dedicated to developing effective, patient-friendly cancer management solutions that are used every day to help individuals with cancer worldwide."
At the Congress's Global Village, Elekta will share its products and insights at its exhibit, which will feature three of its industry leading solutions for advanced radiation therapy:
Copyright©2012 PR Newswire.
All rights reserved